undamentalytics Newsletter

Agios Pharmaceuticals, Inc. trades by members of Congress

Purchases and sales of Agios Pharmaceuticals, Inc. shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

Purchases, last 12 months 3 trades Reported value $3,003–$45,000 (sum of the ranges filed)
Sales, last 12 months 0 trades None disclosed
Members trading, last 12 months 1 8 purchases and sales since January 3, 2015
Agios Pharmaceuticals, Inc. trades disclosed by members of Congress
Report
Gilbert Ray Cisneros, Jr. House · D-CA 31 Purchase$1,001 - $15,000 Sep 10, 2026 Aug 20, 2026 Filing for AGIO on Aug 20, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31 Purchase$1,001 - $15,000 Apr 7, 2026 Mar 3, 2026 Filing for AGIO on Mar 3, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31 Purchase$1,001 - $15,000 Jan 12, 2026 Dec 11, 2025 Filing for AGIO on Dec 11, 2025
Gilbert Ray Cisneros, Jr. House · D-CA 31 Purchase$1,001 - $15,000 May 6, 2025 Apr 17, 2025 Filing for AGIO on Apr 17, 2025
Gilbert Ray Cisneros, Jr. House · D-CA 31 Purchase$1,001 - $15,000 Feb 11, 2025 Jan 29, 2025 Filing for AGIO on Jan 29, 2025
Josh Gottheimer House · D-NJ 5 Purchase$1,001 - $15,000 · Joint Feb 15, 2024 Jan 24, 2024 Filing for AGIO on Jan 24, 2024
Thomas MacArthur House · NJ Sale (full)$1,001 - $15,000 · Joint Jun 7, 2015 May 27, 2015 Filing for AGIO on May 27, 2015
Thomas MacArthur House · NJ Purchase$1,001 - $15,000 · Joint Apr 11, 2015 Mar 18, 2015 Filing for AGIO on Mar 18, 2015

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to Agios Pharmaceuticals, Inc. · Insider trading · Funds · All trades by members of Congress